140 results on '"Torrelo, Antonio"'
Search Results
2. Didymotic Skin Disorders
3. The Major Categories of Mosaicism
4. Mosaicism as a Biological Concept
5. Mosaic Manifestation of Autosomal Dominant Skin Disorders
6. The Archetypical Patterns of Segmental Cutaneous Mosaicism
7. Nevi
8. Other Binary Genodermatoses, in Which Didymosis Is Excluded or Questionable
9. Nevoid Skin Disorders
10. Relationship Between Hypomorphic Alleles and Mosaicism of X-Linked or Autosomal Mutations
11. Less Well-Defined or So Far Unclassifiable Patterns
12. Revertant Mosaicism
13. Pigmented Keratin Granuloma: A Rare Event
14. Introduction
15. Mosaicism in Human Skin
16. Correction to: Mosaicism in Human Skin
17. Relationship Between Hypomorphic Alleles and Mosaicism of X-Linked or Autosomal Mutations
18. Less Well-Defined or So Far Unclassifiable Patterns
19. Introduction
20. Didymotic Skin Disorders
21. Nevoid Skin Disorders
22. The Archetypical Patterns of Segmental Cutaneous Mosaicism
23. Revertant Mosaicism
24. Mosaicism as a Biological Concept
25. The Major Categories of Mosaicism
26. Other Binary Genodermatoses, in Which Didymosis Is Excluded or Questionable
27. Mosaic Manifestation of Autosomal Dominant Skin Disorders
28. Nevi
29. Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA)
30. Italian S3-Guideline on the treatment of atopic eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)
31. Italian S3-Guideline on the treatment of atopic eczema Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)
32. Transient infantile lingual leukoplakia: An underrecognized cause of white tongues in infancy
33. Pediatric Neutrophilic Dermatoses
34. Correspondence
35. Frequency of the prominent transverse nasal root vein in children.
36. NLRP1‐associated autoinflammatory disease with epithelial dyskeratosis.
37. Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials
38. Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment:an updated integrated analysis of eight clinical trials
39. Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS)
40. 66 - Vitiligo and Other Disorders of Hypopigmentation
41. Vulvar erosions in a young girl
42. Atrophic macules containing mesenchymal cells are precursor lesions of osteoma cutis in Albright hereditary osteodystrophy
43. Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials
44. Cutaneous lesions and mitochondrial hearing loss: A case report
45. Germline intergenic duplications at Xq26.1 underlie Bazex–Dupré–Christol basal cell carcinoma susceptibility syndrome
46. The global reach of artificial intelligence in atopic dermatitis: The quality and reliability of ChatGPT responses in 8 languages
47. Idiopathic calcinosis cutis in an infant: The importance of a wait‐and‐see approach.
48. Erythema nodosum after COVID ‐19 vaccine: Report of two pediatric cases
49. Monkeypox disease in a breastfeeding infant
50. 51887 Lebrikizumab Demonstrates Sustained Efficacy in Adolescent Patients Through 2 Years of Continuous Treatment: Results From ADjoin Long-Term Extension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.